Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125242301 | 12524230 | 1 | I | 20160622 | 20160704 | 20160704 | PER | US-009507513-1606USA011137 | MERCK | 7.00 | YR | F | Y | 0.00000 | 20160704 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125242301 | 12524230 | 1 | PS | SINGULAIR | MONTELUKAST SODIUM | 1 | Oral | U | 20830 | CHEWABLE TABLET | |||||||||
| 125242301 | 12524230 | 2 | SS | FLUTICASONE PROPIONATE. | FLUTICASONE PROPIONATE | 1 | Respiratory (inhalation) | 110 MICROGRAM, BID | U | 0 | 110 | UG | BID | ||||||
| 125242301 | 12524230 | 3 | SS | FLUTICASONE PROPIONATE. | FLUTICASONE PROPIONATE | 1 | Respiratory (inhalation) | 110 MICROGRAM, TID | U | 0 | 110 | UG | TID | ||||||
| 125242301 | 12524230 | 4 | C | CETIRIZINE HYDROCHLORIDE. | CETIRIZINE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 125242301 | 12524230 | 5 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125242301 | 12524230 | 1 | Asthma |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125242301 | 12524230 | Drug ineffective |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |